Figure 1.
Overall survival for patients with metastatic or recurrent gastric, gastroesophageal junction or oesophageal adenocarcinoma, regardless of HER2 status (p = 0.5).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.